NDC 50090-1377
BOOSTRIX
Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine, Adsorbed
BOOSTRIX is a Intramuscular Suspension in the Vaccine category. It is labeled and distributed by A-s Medication Solutions. The primary component is Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated); Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated); Bordetella Pertussis Toxoid Antigen (formaldehyde, Glutaraldehyde Inactivated); Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated); Bordetella Pertussis Pertactin Antigen (formaldehyde Inactivated).
| Product ID | 50090-1377_3f58fd2f-0af5-4333-adad-e445e1ee22d9 |
| NDC | 50090-1377 |
| Product Type | Vaccine |
| Proprietary Name | BOOSTRIX |
| Generic Name | Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine, Adsorbed |
| Dosage Form | Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2009-07-24 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125106 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 5 [iU]/.5mL; [iU]/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| Pharm Classes | Inactivated Clostridium Tetani Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Tetanus Toxoid [CS],Inactivated Corynebacterium Diphtheriae Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Diphtheria Toxoid [CS],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Pertussis Vaccine [CS],Vaccines, Inactivated [CS],Pertussis Vaccine [CS],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Pertussis Vaccine [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 50090-1377-0
10 SYRINGE in 1 CARTON (50090-1377-0) > .5 mL in 1 SYRINGE (50090-1377-9)
| Marketing Start Date | 2009-07-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50090-1377-9 [50090137709]
BOOSTRIX SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125106 |
| Product Type | VACCINE |
| Marketing Start Date | 2009-07-24 |
NDC 50090-1377-0 [50090137700]
BOOSTRIX SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125106 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2009-07-24 |
NDC 50090-1377-1 [50090137701]
BOOSTRIX SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125106 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2009-07-24 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | 5 [iU]/.5mL |
Pharmacological Class
- Inactivated Clostridium Tetani Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Tetanus Toxoid [CS]
- Inactivated Corynebacterium Diphtheriae Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Diphtheria Toxoid [CS]
- Inactivated Bordetella Pertussis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Pertussis Vaccine [CS]
- Vaccines
- Inactivated [CS]
- Pertussis Vaccine [CS]
- Inactivated Bordetella Pertussis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Inactivated Bordetella Pertussis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Pertussis Vaccine [CS]
NDC Crossover Matching brand name "BOOSTRIX" or generic name "Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine, Adsorbed"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-1377 | BOOSTRIX | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
| 50090-1831 | BOOSTRIX | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
| 58160-842 | BOOSTRIX | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
Trademark Results [BOOSTRIX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BOOSTRIX 79269514 not registered Live/Pending |
GlaxoSmithKline Biologicals S.A. 2019-08-27 |
 BOOSTRIX 78549441 not registered Dead/Abandoned |
GlaxoSmithKline Biologicals S.A. 2005-01-18 |
 BOOSTRIX 76467131 2905576 Live/Registered |
GLAXOSMITHKLINE BIOLOGICALS S.A. 2002-11-14 |
 BOOSTRIX 75901449 not registered Dead/Abandoned |
SmithKline Beecham Biologicals, S.A. 2000-01-20 |
 BOOSTRIX 75131458 not registered Dead/Abandoned |
SmithKline Beecham Biologicals S.A. 1996-07-09 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.